Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-088545
Filing Date
2025-06-20
Accepted
2025-06-20 16:33:47
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5736
  Complete submission text file 0000950170-25-088545.txt   7143
Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Bogle Grant C. (Reporting) CIK: 0001646675 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40671 | Film No.: 251061937

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)